This inventor holds 5 USPTO granted patents. Top assignees: Incyte Corporation, H. Lee Moffitt Cancer Center and Research Institute, Inc., Other. Active years: 2002-2025.
IDiyas Innovation Intelligence. (2026). Inventor Profile: Holly Koblish. Retrieved from https://idiyas.com/inventor/holly-koblish
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
% Patents Active = 100.0
Average Co-Inventor Count = 2.1
ph-index = 2
Forward Citations = 29(Granted Patents)
Location History:
- Yardley, PA (US) (2002)
- Exton, PA (US) (2020 - 2024)
Company Filing History:
4 out of 687 
Incyte Corporation
2 out of 312 
H. Lee Moffitt Cancer Center and Research Institute, Inc.
1 out of 834,570 Other
where one patent can have more than one assignee
Years Active: 2002-2025
Loading Chart...
5 patents (USPTO):Explore Patents
3. 11278541 - Low dose combination therapy for treatment of myeloproliferative neoplasms (2022-03-22),
Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
IDiyas Innovation Intelligence. (2026). Inventor Profile: Holly Koblish. Retrieved from https://idiyas.com/inventor/holly-koblish
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]